The use of proteomics to understand antiviral immunity

Amanda P. Woon, Anthony W. Purcell

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Viruses are intracellular pathogens that cause a vast array of diseases, which are often severe and typified by high morbidity and mortality rates. Viral infections continue to be a global health burden and effective vaccines and therapeutics are constantly sought to prevent and treat these infections. The development of such treatments generally relies on understanding the mechanisms that underpin efficient host antiviral immune responses. This review summarises recent developments in our understanding of antiviral adaptive immunity and in particular, highlights the use of mass spectrometry to elucidate viral antigens and their processing and presentation to T cells and other immune effectors. These processed peptides serve as potential vaccine candidates or may facilitate clinical monitoring, diagnosis and immunotherapy of infectious diseases.

Original languageEnglish
Pages (from-to)22-29
Number of pages8
JournalSeminars in Cell and Developmental Biology
Volume84
DOIs
Publication statusPublished - 1 Dec 2018

Keywords

  • Antigen presentation
  • Antigen processing
  • Immunopeptidomics
  • Mass spectrometry
  • Proteomics
  • Virus

Cite this

@article{f3248d9b4c2c4316a3a24cbe59dd43e3,
title = "The use of proteomics to understand antiviral immunity",
abstract = "Viruses are intracellular pathogens that cause a vast array of diseases, which are often severe and typified by high morbidity and mortality rates. Viral infections continue to be a global health burden and effective vaccines and therapeutics are constantly sought to prevent and treat these infections. The development of such treatments generally relies on understanding the mechanisms that underpin efficient host antiviral immune responses. This review summarises recent developments in our understanding of antiviral adaptive immunity and in particular, highlights the use of mass spectrometry to elucidate viral antigens and their processing and presentation to T cells and other immune effectors. These processed peptides serve as potential vaccine candidates or may facilitate clinical monitoring, diagnosis and immunotherapy of infectious diseases.",
keywords = "Antigen presentation, Antigen processing, Immunopeptidomics, Mass spectrometry, Proteomics, Virus",
author = "Woon, {Amanda P.} and Purcell, {Anthony W.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.semcdb.2017.12.002",
language = "English",
volume = "84",
pages = "22--29",
journal = "Seminars in Cell and Developmental Biology",
issn = "1084-9521",
publisher = "Elsevier",

}

The use of proteomics to understand antiviral immunity. / Woon, Amanda P.; Purcell, Anthony W.

In: Seminars in Cell and Developmental Biology, Vol. 84, 01.12.2018, p. 22-29.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - The use of proteomics to understand antiviral immunity

AU - Woon, Amanda P.

AU - Purcell, Anthony W.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Viruses are intracellular pathogens that cause a vast array of diseases, which are often severe and typified by high morbidity and mortality rates. Viral infections continue to be a global health burden and effective vaccines and therapeutics are constantly sought to prevent and treat these infections. The development of such treatments generally relies on understanding the mechanisms that underpin efficient host antiviral immune responses. This review summarises recent developments in our understanding of antiviral adaptive immunity and in particular, highlights the use of mass spectrometry to elucidate viral antigens and their processing and presentation to T cells and other immune effectors. These processed peptides serve as potential vaccine candidates or may facilitate clinical monitoring, diagnosis and immunotherapy of infectious diseases.

AB - Viruses are intracellular pathogens that cause a vast array of diseases, which are often severe and typified by high morbidity and mortality rates. Viral infections continue to be a global health burden and effective vaccines and therapeutics are constantly sought to prevent and treat these infections. The development of such treatments generally relies on understanding the mechanisms that underpin efficient host antiviral immune responses. This review summarises recent developments in our understanding of antiviral adaptive immunity and in particular, highlights the use of mass spectrometry to elucidate viral antigens and their processing and presentation to T cells and other immune effectors. These processed peptides serve as potential vaccine candidates or may facilitate clinical monitoring, diagnosis and immunotherapy of infectious diseases.

KW - Antigen presentation

KW - Antigen processing

KW - Immunopeptidomics

KW - Mass spectrometry

KW - Proteomics

KW - Virus

UR - http://www.scopus.com/inward/record.url?scp=85056583391&partnerID=8YFLogxK

U2 - 10.1016/j.semcdb.2017.12.002

DO - 10.1016/j.semcdb.2017.12.002

M3 - Review Article

VL - 84

SP - 22

EP - 29

JO - Seminars in Cell and Developmental Biology

JF - Seminars in Cell and Developmental Biology

SN - 1084-9521

ER -